Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 120, Issue 5, Pages 547-554
Publisher
Springer Nature
Online
2019-02-12
DOI
10.1038/s41416-019-0398-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
- (2018) Daniela S. Thommen et al. NATURE MEDICINE
- Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer
- (2018) Si-yang Liu et al. LUNG CANCER
- Aligning digital CD8+ scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma
- (2017) Esther Conde et al. HISTOPATHOLOGY
- Prognostic value of PD-L1 expression in combination with CD8+ TILs density in patients with surgically resected non-small cell lung cancer
- (2017) Hui Yang et al. Cancer Medicine
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
- (2016) Young Kwang Chae et al. Clinical Lung Cancer
- Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma
- (2016) Ching-Yao Yang et al. EUROPEAN JOURNAL OF CANCER
- Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
- (2016) Masaya Yotsukura et al. Journal of Thoracic Oncology
- Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases
- (2016) Jong-Mu Sun et al. Journal of Thoracic Oncology
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome
- (2016) Marius Ilie et al. MODERN PATHOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Prognostic Significance of Tumor-infiltrating CD8+or CD3+T Lymphocytes and Interleukin-2 Expression in Radically Resected Non-small Cell Lung Cancer
- (2015) Liuxing Wang et al. CHINESE MEDICAL JOURNAL
- Stromal CD8+ T-cell Density--A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
- (2015) T. Donnem et al. CLINICAL CANCER RESEARCH
- PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
- (2015) Wendy A. Cooper et al. LUNG CANCER
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasticity in programming of effector and memory CD8+T-cell formation
- (2015) Ramon Arens et al. IMMUNOLOGICAL REVIEWS
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Tumour-Infiltrating FoxP3+ and IL-17-Producing T Cells Affect the Progression and Prognosis of Gallbladder Carcinoma after Surgery
- (2013) Y. Zhang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Video-assisted thoracoscopic surgery for stage I non-small cell lung cancer: long-term survival and prognostic factors
- (2013) Xinguo Xiong et al. TUMOR BIOLOGY
- Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
- (2011) Cameron J Turtle et al. CURRENT OPINION IN IMMUNOLOGY
- Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
- (2010) Yan Zhang et al. Cellular & Molecular Immunology
- Cancer immunoediting and “spontaneous” tumor regression
- (2009) Neel Sengupta et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- How tumours escape mass destruction
- (2008) T J Stewart et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now